Citadel Advisors’s INVO Fertility Inc IVF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,738
Closed -$17.8K 14568
2025
Q4
$17.8K Buy
4,738
+3,067
+184% +$53.4K ﹤0.01% 12364
2025
Q3
$50.8K Buy
+1,671
New +$107K ﹤0.01% 12197
2024
Q4
Sell
-37
Closed -$37.4K 15596
2024
Q3
$37.4K Buy
+37
New +$42.3K ﹤0.01% 12224
2023
Q4
Sell
-25
Closed -$28.6K 15422
2023
Q3
$28.6K Buy
+25
New +$78.9K ﹤0.01% 12312
2023
Q1
Sell
-2
Closed -$21.2K 15664
2022
Q4
$21.2K Buy
+2
New +$54.6K ﹤0.01% 13101
2022
Q3
Sell
-1
Closed -$15K 13786
2022
Q2
$15K Hold
1
﹤0.01% 12500
2022
Q1
$68K Buy
+1
New +$86.7K ﹤0.01% 12600
2021
Q2
Sell
-1
Closed -$98K 14579
2021
Q1
$98K Buy
+1
New +$110K ﹤0.01% 12499

Other funds holding IVF

Citadel Advisors's IVF Position: Q1 2026 in Review

Citadel Advisors sold out of INVO Fertility Inc (IVF) in Q1 2026, closing a stake of 4,738 shares — an estimated $17.8K sold.

Citadel Advisors first reported a position in IVF in Q1 2021 and held it in 8 quarters. The position peaked at $98K in Q1 2021. 8 funds tracked by Wall St. Rank hold IVF as of Q1 2026.

  • Citadel Advisors reported no remaining INVO Fertility Inc position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 4,738 INVO Fertility Inc shares in Q1 2026, an estimated $17.8K.
  • Citadel Advisors first reported a position in INVO Fertility Inc in Q1 2021 and held it in 8 quarters.
  • Citadel Advisors's INVO Fertility Inc position peaked at $98K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held INVO Fertility Inc as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.